Zhitong Finance App learned that Sihuan Pharmaceutical (00460.HK) recently underwent an optimization and upgrade of its governance structure and announced the appointment of Mr. Che Yuxuan as a non-executive director of the company and a member of the Board Risk Management Committee, effective August 26, 2026. With its international research background and diverse perspectives, the addition of a new non-executive director is expected to inject new momentum into the company's commercialization of innovative drug pipelines and the empowerment of AI research and development.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.